Table 6.
Association of HLA haplotype with female in MS patients of Khuzestan province
| HLA haplotypes | Patients | Controls | p value | |||
|---|---|---|---|---|---|---|
| posetive haplotype (%) | Total | posetive haplotype (%) | Total | |||
| 1 | DRB5*01+-DQB1*0602- | 6 (4.20) | 149 | 2 (20.06) | 97 | 0.396 |
| 2 | DRB5*01--DQB1*0602- | 53 (39.84) | 133 | 36(33.96) | 106 | 0.350 |
| 3 | DRB5*01+-DQB1*0602+ | 35 (23.80) | 147 | 18 (14.47) | 103 | 0.228 |
| 4 | DRB5*01--DQB1*0602+ | 48 (32.65) | 147 | 43 (40.95) | 105 | 0.176 |
| 5 | DRB5*01+-DRB1*1501+-DQB1*0602+ | 14 (9.79) | 143 | 13 (10.40) | 125 | 0.869 |
| 6 | DRB5*01+ -DRB1*1501+ -DQB1*0602- | 3 (1.94) | 154 | 0 (0) | 107 | 0.146 |
| 7 | DRB5*01--DRB1*1501+- DQB1*0602+ | 18 (12.16) | 148 | 7 (7.52) | 93 | 0.251 |
*=significant P values; Statistical significance was at p < 0.05. Values are expressed as No. (%).